Inventor

SALVATI MARK E

US33 patents

⚠️ This page may combine multiple inventors who share the name “SALVATI MARK E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SALVATI MARK E

BRISTOL MYERS SQUIBB CO

Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator

Bicyclic modulators of androgen receptor function

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Fused cyclic modulators of nuclear hormone receptor function

Heterocyclic CETP inhibitors

Heterocyclic CETP inhibitors

Bicyclic modulators of androgen receptor function

Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders

Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

Process for preparing azacycloalkanoylaminothiazoles

Crystallographic structure of the androgen receptor ligand binding domain

Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function

Fused heterocyclic imido and amido compounds

Tricycloundecane compounds useful as modulators of nuclear hormone receptor function

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Process for preparing azacycloalkanoylaminothiazoles

Fused cyclic modulators of nuclear hormone receptor function

Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

Process for preparing azacycloalkanoylaminothiazoles (LD 137e)

3-Aminopyrazole inhibitors of cyclin dependent kinases

3-aminopyrazole inhibitors of cyclin dependent kinases

Crystallographic structure of the androgen receptor ligand binding domain

Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function

SALVATI MARK E

Heterocyclic CETP inhibitors

Heterocyclic CETP inhibitors

N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

AMERICAN CYANAMID CO

Substituted 3-cyanoquinolines

Substituted dibenzothiophenes having antiangiogenic activity